天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

5’-Deoxy-5-fluoro-N-[{pentyloxy)carbonyl]-3’-acetate cytidine

5’-Deoxy-5-fluoro-N-[{pentyloxy)carbonyl]-3’-acetate cytidine Struktur
1262133-70-9
CAS-Nr.
1262133-70-9
Englisch Name:
5’-Deoxy-5-fluoro-N-[{pentyloxy)carbonyl]-3’-acetate cytidine
Synonyma:
Capecitabine Impurity 30;Cytidine, 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 3'-acetate
CBNumber:
CB86008284
Summenformel:
C17H24FN3O7
Molgewicht:
401.39
MOL-Datei:
1262133-70-9.mol

5’-Deoxy-5-fluoro-N-[{pentyloxy)carbonyl]-3’-acetate cytidine Eigenschaften

Dichte
1.44±0.1 g/cm3(Predicted)
pka
5.40±0.40(Predicted)

Sicherheit

5’-Deoxy-5-fluoro-N-[{pentyloxy)carbonyl]-3’-acetate cytidine Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

5’-Deoxy-5-fluoro-N-[{pentyloxy)carbonyl]-3’-acetate cytidine is a derivative of Capecitabine (C175650), an antineoplastic agent and a prodrug of Doxifluridine (D556750).

5’-Deoxy-5-fluoro-N-[{pentyloxy)carbonyl]-3’-acetate cytidine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5’-Deoxy-5-fluoro-N-[{pentyloxy)carbonyl]-3’-acetate cytidine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11922 58
Jinan blalong chemical co. LTD 2710913286@.com
 1513643261@qq.com China 14246 58
Jiangsu Wansipu Technology Co., Ltd. 17826022701
 1485609990@qq.com China 952 58
HX Pharmaceutical technology co., LTD 15671363360
 494267389@qq.com China 3523 58
Shanghai Zerui Biotechnology Co., Ltd. 021-54580889 18321124657
 731997554@qq.com China 10608 58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233; 18502726233
 3641133981@qq.com China 9711 58
  • Capecitabine Impurity 30
  • Cytidine, 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 3'-acetate
  • 1262133-70-9
  • C17H24FN3O7
Copyright 2019 ? ChemicalBook. All rights reserved